The Alzheimer's Disease Genetics Consortium (ADGC) is funded by a grant from the National Institute on Aging (PI, Gerard D. Schellenberg; UO1AG032984), an $18.3 million five-year research grant to conduct genome-wide association studies (GWAS) to identify genes associated with an increased risk of developing late-onset Alzheimer’s disease (LOAD). (Penn Medicine Press Release)

CADRE/ADGC Announce Trans-Institutional Seminar Series

The Collaborative for Alzheimer’s Disease Research (CADRE) and the Alzheimer’s Disease Genetics Consortium (ADGC) are creating a new multi-institutional seminar series to support next generation researchers in Alzheimer’s disease process, diagnosis and care by encouraging collaboration within the AD research community. The new Trans-Institutional Seminar Series will highlight up-and-coming junior investigators to help strengthen their professional development, foster growth, and enhance knowledge and skills.

The first seminar will be May 12, 2021. Dr. Anthony Griswold will present on Transcriptomic Approaches to Alzheimer Disease in Diverse Ancestral Populations. His presentation will be posted to the CADRE site later that week.

For more information and updates, please visit: the CADRE Website